Cohen Pitched Novartis Russia-Tied Investment, Democrats Say
- Senators release report exposing possible quid pro quo deal
- Novartis offered list of ideas on how to cut drug prices
This article is for subscribers only.
Michael Cohen, longtime lawyer to President Donald Trump, not only took money from companies looking for insight into the new administration but also pressed one of his clients to take up an investment opportunity to benefit Russian-linked Columbus Nova, another client.
The disclosure, contained in a report produced by an investigation led by Senate Democrats, shows that Cohen promoted the investment in a company backed by Columbus Nova to Novartis AG. Novartis in turn offered a list of ideas on how to lower drug prices and sent it to Cohen, who promised to pass it along to the administration, according to the report.